Page last updated: 2024-11-03

propranolol and Epithelial Ovarian Cancer

propranolol has been researched along with Epithelial Ovarian Cancer in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramondetta, LM1
Hu, W1
Thaker, PH1
Urbauer, DL1
Chisholm, GB1
Westin, SN1
Sun, Y1
Ramirez, PT1
Fleming, N1
Sahai, SK1
Nick, AM1
Arevalo, JMG1
Dizon, T1
Coleman, RL1
Cole, SW1
Sood, AK1

Trials

1 trial available for propranolol and Epithelial Ovarian Cancer

ArticleYear
Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression.
    Gynecologic oncology, 2019, Volume: 154, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc

2019